Barclays PLC Buys 17,931 Shares of Blueprint Medicines Co. (NASDAQ:BPMC)
Barclays PLC raised its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 10.5% during the 4th quarter, HoldingsChannel reports. The firm owned 189,127 shares of the biotechnology company’s stock after purchasing an additional 17,931 shares during the quarter. Barclays PLC’s holdings in Blueprint Medicines were worth $16,494,000 as of its most […]
Barclays PLC raised its stake in shares of Blueprint Medicines Co. (NASDAQ:BPMC – Free Report) by 10.5% during the 4th quarter, HoldingsChannel reports. The firm owned 189,127 shares of the biotechnology company’s stock after purchasing an additional 17,931 shares during the quarter. Barclays PLC’s holdings in Blueprint Medicines were worth $16,494,000 as of its most […]
